JANUX Trademark

Trademark Overview

On Monday, March 29, 2021, a trademark application was filed for JANUX with the United States Patent and Trademark Office. The USPTO has given the JANUX trademark a serial number of 90610956. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Monday, August 18, 2025. This trademark is owned by JANUX THERAPEUTICS, INC.. The JANUX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; drug discovery services; biomedical research services; laboratory research services relating to pharmaceuticals, namely, research in the field of oncology and immunotherapy
janux

General Information

Serial Number90610956
Word MarkJANUX
Filing DateMonday, March 29, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateMonday, August 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements

Goods and ServicesPharmaceutical research and development; drug discovery services; biomedical research services; laboratory research services relating to pharmaceuticals, namely, research in the field of oncology and immunotherapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 6, 2021
Primary Code042
First Use Anywhere DateMonday, November 30, 2020
First Use In Commerce DateMonday, November 30, 2020

Trademark Owner History

Party NameJANUX THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego,, CA 92130
Party NameJANUX THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events

Event DateEvent Description
Friday, November 5, 2021ASSIGNED TO EXAMINER
Saturday, November 20, 2021NON-FINAL ACTION WRITTEN
Thursday, May 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 1, 2021NEW APPLICATION ENTERED
Tuesday, July 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 20, 2021NON-FINAL ACTION E-MAILED
Saturday, November 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 21, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 15, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 15, 2023SOU EXTENSION 2 FILED
Tuesday, August 15, 2023SOU EXTENSION 2 GRANTED
Thursday, August 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 9, 2024SOU EXTENSION 3 FILED
Friday, February 9, 2024SOU EXTENSION 3 GRANTED
Friday, February 9, 2024SOU TEAS EXTENSION RECEIVED
Saturday, February 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2024SOU EXTENSION 4 GRANTED
Tuesday, August 20, 2024SOU EXTENSION 4 FILED
Tuesday, September 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 21, 2023SOU EXTENSION 1 FILED
Tuesday, February 21, 2023SOU EXTENSION 1 GRANTED
Thursday, February 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 19, 2025SOU EXTENSION 5 FILED
Thursday, February 20, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, June 4, 2025SOU EXTENSION 5 GRANTED
Thursday, August 14, 2025USE AMENDMENT FILED
Monday, August 18, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 14, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, June 3, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

janux research services namely pharmaceuticals oncology immunotherapy relating field biomedical development